Guangdong VTR Bio-Tech Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 4.98%

Guangdong VTR Bio-Tech Co Ltd (300381) has an Asset Resilience Ratio of 4.98% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥143.28 Million

≈ $20.97 Million USD Cash + Short-term Investments

Total Assets

CN¥2.88 Billion

≈ $421.34 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2025)

This chart shows how Guangdong VTR Bio-Tech Co Ltd's Asset Resilience Ratio has changed over time. Check Guangdong VTR Bio-Tech Co Ltd (300381) strategic asset index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Guangdong VTR Bio-Tech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300381 stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥143.28 Million	4.98%
Total Liquid Assets	CN¥143.28 Million	4.98%

Asset Resilience Insights

Limited Liquidity: Guangdong VTR Bio-Tech Co Ltd maintains only 4.98% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Guangdong VTR Bio-Tech Co Ltd Industry Peers by Asset Resilience Ratio

Compare Guangdong VTR Bio-Tech Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	0.05%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Syndax Pharmaceuticals Inc NASDAQ:SNDX	Biotechnology	46.79%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	63.47%
Chengdu Kanghua Biological Products SHE:300841	Biotechnology	1.19%
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	Biotechnology	4.35%

Annual Asset Resilience Ratio for Guangdong VTR Bio-Tech Co Ltd (2014–2025)

The table below shows the annual Asset Resilience Ratio data for Guangdong VTR Bio-Tech Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	6.79%	CN¥198.72 Million ≈ $29.08 Million	CN¥2.92 Billion ≈ $428.01 Million	-4.47pp
2024-12-31	11.26%	CN¥332.13 Million ≈ $48.60 Million	CN¥2.95 Billion ≈ $431.47 Million	-6.95pp
2023-12-31	18.21%	CN¥563.70 Million ≈ $82.49 Million	CN¥3.09 Billion ≈ $452.89 Million	-3.50pp
2022-12-31	21.72%	CN¥688.89 Million ≈ $100.81 Million	CN¥3.17 Billion ≈ $464.18 Million	+21.56pp
2016-12-31	0.16%	CN¥5.00 Million ≈ $731.66K	CN¥3.21 Billion ≈ $469.70 Million	-12.30pp
2014-12-31	12.46%	CN¥120.04 Million ≈ $17.57 Million	CN¥963.36 Million ≈ $140.97 Million	--

pp = percentage points

About Guangdong VTR Bio-Tech Co Ltd

SHE:300381 China Biotechnology

Market Cap

$419.65 Million

CN¥2.87 Billion CNY

Market Cap Rank

#13021 Global

#3810 in China

Share Price

CN¥5.84

Change (1 day)

+1.92%

52-Week Range

CN¥5.40 - CN¥7.99

All Time High

CN¥34.00